📰 Critically Ill News
Critically Ill News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Critically Ill. Real-time updates on events, politics, business and more.
May 21, 2024
JENA, Germany, May 21, 2024 -- InflaRx N.V. , a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced data presented at the American...
January 13, 2024
1. Families randomized to having access to a mobile application that allowed them to communicate needs with intensive care unit (ICU) physicians were found to have reduced unmet palliative care needs compared to usual care. 2. White families were observed to benefit more from the intervention than Black families as measured by the Needs at
January 9, 2024
An air ambulance was sent to the scene of the crash on the A19 near Easingwold on Monday.
December 20, 2023
Police said "extensive" inquiries into the attack on the two males, aged 17 and 18, were underway.
November 13, 2023
LONDON/ROME (Reuters) -Indi Gregory, a critically ill eight-month-old baby girl from Britain who was taken off life support over the weekend following a legal battle, has died overnight, her family said on Monday. The baby died at 0145 GMT, Dean Gregory, her father, said in a statement issued by charity Christian Concern.
November 13, 2023
LONDON/ROME (Reuters) -Indi Gregory, a critically ill eight-month-old baby girl from Britain who was taken off life support over the weekend following a legal battle, has died overnight, her family said on Monday. The baby died at 0145 GMT, Dean Gregory, her father, said in a statement issued by charity Christian Concern.
November 12, 2023
UK judges insisted it was in Indi Gregory's best interest to peacefully die in hospice care despite calls from her parents to send her to Italy.
November 4, 2023
Indi Gregory's parents wanted to overturn a decision to refuse a transfer to a hospital in Italy.
November 1, 2023
Jena, Germany, November 1, 2023 - InflaRx N.V. , a biotechnology company pioneering anti-inflammatory therapeutics targeting the complement system, announced today financial results...
November 1, 2023
Single ascending dose (SAD) Phase I data confirm best-in-class potential of orally available C5aR inhibitor INF904; multiple ascending dose (MAD) ...